An Observational Study of Burden of Upper GI-Symptoms in CV Risk Patients

Completed

Conditions studied: Cardiovascular Disease

In brief

The purpose of this study is to investigate the burden of upper gastrointestinal symptoms in patients with cardiovascular disease taking low dose aspirin

Key facts

Study ID

NCT00681759

Run by

AstraZeneca

People needed

1836

Starts

2008-01-01

Expected to finish

2008-09-01

Last updated by the study team

2008-10-31

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Provision of signed written inform consent.
• Physician prescribed or recommended daily intake of Low Dose Aspirin (LDA) (75-325 mg daily) for cardiovascular disease prevention within the past 12 months.
• Established cardiovascular disease, such as CAD (CoronaryArtery Disease), previous TIA (Transient Ischemic Attack), ischemic stroke or subjects with known risk factors for cardiovascular disease without having experienced cardiovascular events

You may not qualify if…

• Need for concomitant treatment with a non-ASA NSAID (Nonsteroidal Antiinflammatory Drugs) including acyclooxygenase-2 (COX-2) selective NSAID. Occasional use of up to 1 day/week is allowed.

Where it is running

• Research Site — Brentwood, Tennessee, United States
• Research Site — Saint-Laurent, Quebec, Canada
• Research Site — Paris, France

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.